Literature DB >> 22286968

Surgical management of normocalcemic primary hyperparathyroidism.

Thomas J Wade1, Tina W F Yen, Amanda L Amin, Tracy S Wang.   

Abstract

BACKGROUND: Primary hyperparathyroidism (pHPT), typically defined as elevated serum calcium levels associated with inappropriately elevated parathyroid hormone (PTH) levels, can occur also in patients with normal serum calcium levels. This study investigated the characteristics, workup, and surgical management of patients with normocalcemic pHPT.
METHODS: A retrospective chart review of a prospectively collected, single-institution parathyroid database was performed on patients with sporadic pHPT who underwent parathyroidectomy between 12/99 and 12/08.
RESULTS: In all, 93 of 771 (12%) pHPT patients had normal serum calcium levels 3 months prior to surgery. Ionized calcium (iCa) levels were available for 58 patients and were elevated in 50 (86%). Among those with elevated iCa levels 90% had single-gland disease (SGD), whereas 63% with normal iCa levels had SGD (p = 0.07). Preoperative imaging identified SGD in 60% of patients with normal iCa and in 66% with elevated iCa levels. Intraoperative PTH (IOPTH) monitoring identified cure in 51 of 58 (88%) patients including 6 (75%) with normal iCa. At a median follow-up of 358 days, postoperative calcium and PTH levels were similar in the groups. One (1%) patient had recurrent disease.
CONCLUSIONS: Most patients with apparent normocalcemic pHPT have elevated ionized calcium levels. For patients with normocalcemic pHPT, we recommend measuring iCa levels preoperatively, performing localization studies, and utilizing IOPTH monitoring to guide a successful operation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286968     DOI: 10.1007/s00268-012-1438-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 2.  Normocalcemic hyperparathyroidism.

Authors:  J M Monchik
Journal:  Surgery       Date:  1995-12       Impact factor: 3.982

3.  Ionized calcium in the diagnosis of primary hyperparathyroidism.

Authors:  J M Monchik; H F Martin
Journal:  Surgery       Date:  1980-08       Impact factor: 3.982

4.  Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.

Authors:  E Lundgren; J Rastad; E Thrufjell; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1997-03       Impact factor: 3.982

5.  Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.

Authors:  Ewa Lundgren; Emil G Hagström; Jonas Lundin; Kajsa Winnerbäck; Johanna Roos; Sverker Ljunghall; Jonas Rastad
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

6.  The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism.

Authors:  M K McLeod; J M Monchik; H F Martin
Journal:  Surgery       Date:  1984-06       Impact factor: 3.982

7.  Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach.

Authors:  Tina W F Yen; Tracy S Wang; Kara M Doffek; Elizabeth A Krzywda; Stuart D Wilson
Journal:  Surgery       Date:  2008-10       Impact factor: 3.982

8.  Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.

Authors:  H Lowe; D J McMahon; M R Rubin; J P Bilezikian; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

Review 9.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  R Eastell; A Arnold; M L Brandi; E M Brown; P D'Amour; D A Hanley; D Sudhaker Rao; M R Rubin; D Goltzman; S J Silverberg; S J Marx; M Peacock; L Mosekilde; R Bouillon; E M Lewiecki
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 10.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

View more
  18 in total

Review 1.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

Review 2.  Normocalcemic primary hyperparathyroidism.

Authors:  Natalie E Cusano; Shonni J Silverberg; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

3.  The Significance of Histologically "Large Normal" Parathyroid Glands in Primary Hyperparathyroidism.

Authors:  Russel Krawitz; Anthony Glover; Sireesha Koneru; James Jiang; Aimee Di Marco; Anthony J Gill; Ahmad Aniss; Mark Sywak; Leigh Delbridge; Stan Sidhu
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 4.  Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.

Authors:  Joaquín Gómez-Ramírez; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

5.  Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.

Authors:  R Cesareo; E Di Stasio; F Vescini; G Campagna; R Cianni; V Pasqualini; F Romitelli; F Grimaldi; S Manfrini; A Palermo
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

6.  Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.

Authors:  Claire E Graves; Catherine M McManus; John A Chabot; James A Lee; Jennifer H Kuo
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

7.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

8.  Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?

Authors:  Emanuela Traini; Rocco Bellantone; Serena Elisa Tempera; Salvatore Russo; Carmela De Crea; Celestino Pio Lombardi; Marco Raffaelli
Journal:  Langenbecks Arch Surg       Date:  2018-03-14       Impact factor: 3.445

Review 9.  Bone disease in primary hyperparathyroidism.

Authors:  Francisco Bandeira; Natalie E Cusano; Barbara C Silva; Sara Cassibba; Clarissa Beatriz Almeida; Vanessa Caroline Costa Machado; John P Bilezikian
Journal:  Arq Bras Endocrinol Metabol       Date:  2014-07

10.  Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations.

Authors:  Natalie E Cusano; Naim M Maalouf; Patty Y Wang; Chiyuan Zhang; Serge C Cremers; Elizabeth M Haney; Douglas C Bauer; Eric S Orwoll; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.